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Non-small cell lung cancer (NSCLC) accounts for ~80-85% of all lung cancer cases, and the 22 
EML4-ALK fusion oncogene is a well-known contributor to NSCLC cases. Expensive methods 23 
such as FISH, IHC, and NGS have previously been used to detect the EML4-ALK fusion 24 
oncogene. Here, a cost-effective and facile method of detecting and differentiating an EML4-25 
ALK fusion oncogene from the wildtype gene has been accomplished by hybridization using the 26 
microfluidic biochip. First, oligonucleotide probes were confirmed for successful detection of 27 
immobilized sense strands. Second, capture of the sense PCR product strands (fusion and WT) 28 
and their subsequent detection and differentiation were accomplished. Our proof-of-concept 29 
study shows the ability to detect 1% fusion products, among WT ones. 30 
 31 
                                               32 

















Non-small cell lung cancer (NSCLC) accounts for ~80-85% of all lung cancer cases (1, 2). One 48 
genetic mutation among the NSCLC cases is caused by the fusion of the EML4 gene and the 49 
ALK gene (3). Both the genes of EML4 (echinoderm microtubule-associated protein-like 4) and 50 
ALK (anaplastic lymphoma kinase) are located on chromosome 2, separated by ~12 megabases, 51 
and the fusion of these genes occurs to produce the EML4-ALK fusion oncogene (4). The 52 
expression of this fusion gene results in uncontrolled cell proliferation (5, 6). 53 
There are many variants of the EML4-ALK fusion oncogene with the differences in the site of 54 
fusion (7). The most prevalent mutation is variant 1 (7-9), in which the fusion occurs between 55 
exon 20 of ALK and EML4 exon 13 (10). 56 
Detection of the EML4-ALK gene fusion has been achieved by using techniques such as real 57 
time polymerase chain reaction (RT-PCR) (7, 11, 12), DNA microarrays (13-15), fluorescence in 58 
situ hybridization (FISH) (16-18), immunohistochemistry (IHC) (16-18), or next-generation 59 
sequencing (NGS) (16, 18, 19), which are expensive methods. In this proof-of-concept study, a 60 
microfluidic biochip is used in which DNA hybridization occurs to allow for the cost-effective 61 
detection of the wildtype and fusion gene sequences in a sample. The biochip contains 62 
microchannels through which microliters of sample solutions can be injected for hybridization 63 
with the immobilized components on the biochip surface, and this method has previously been 64 
used to detect KRAS mutations (20, 21). By using the biochip made in the lab, we have greater 65 
control over the target sequences and the probes which are to be used for hybridization. 66 
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Therefore, the use of the biochip hybridization method requires low sample consumption (i.e. 67 
nanograms of samples) and flexible choice of probes, which makes this a cost-efficient method. 68 
Materials and Methods 69 
There were no human or animal subjects used in this study.  70 
 71 
Microfluidic biochip Formation  72 
The 16-microchannel biochip consists of a polydimethylsiloxane (PDMS) slab and a 73 
functionalized glass slide (Fig. 1). The PDMS slab was synthesized in the lab by mixing the 74 
elastomer with a curing agent, then pouring the solution onto a mold and allowing it to cure at 75 
22°C (22). After removal of the slab from the mold, holes were punched into the slab at the ends 76 
of the sixteen trenches. The slab was then reversibly sealed onto a functionalized glass slide so 77 
that trenches became microchannels and holes became wells. Afterwards, solutions were injected 78 
on the wells for introduction into the microchannels and allowed to react with the glass slide 79 
surface (Fig. 1). 80 
 81 
Glass Slide Functionalization 82 
A 75 mm x 50 mm glass slide was first cleaned with 100 mL of Piranha solution consisting of 70 83 
mL of 98% H2SO4 and 30 mL of 30% H2O2 for 15 min. After drying, the slide was treated with a 84 
(3-aminopropyl)triethoxysilane (APTES) solution containing 2 mL APTES and 98 mL ethanol 85 
(95%) for 20 min. This reaction was conducted under an inert N2 atmosphere and was followed 86 
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by heating the slide at 120°C for 1 h. The slide was then reacted with a 100 mL 5% 87 
glutaraldehyde solution in 1x phosphate-buffered saline (PBS) for 1 h.  88 
 89 
DNA Oligomer Sequences 90 
The EML4-ALK fusion and the wildtype ALK sequence were cross-referenced with the National 91 
Center for Biotechnology Information (NCBI) and the European Nucleotide Archive (ENA) 92 
databases to ensure sequence accuracy. Target strands and detection probes were ordered from 93 
Integrated DNA Technologies (IDT). Oligonucleotide probes were designed, and they were 94 
either complementary to the EML4 portion of the gene fusion (EML4 probe) or complementary 95 
to the ALK portion (ALK probes 1 and 2), and they were biotin-labelled on their 5’ ends for 96 
detection. An 85-mer target sequence (fusion oligomer) was designed encompassing the site of 97 
the EML4-ALK fusion such that it contained both the EML4 and ALK portions of the fusion 98 
allowing it to bind to both the EML4 and ALK probes. A 55-mer target (WT oligomer) was 99 
designed consisting of the wildtype ALK sequence such that the WT probe would hybridize but 100 
the EML4 probe would not.  101 
Two oligomers (gBlock gene fragments) were obtained to serve as double-stranded templates for 102 
producing PCR products for the fusion and wild-type ALK sequences. Two forward primers 103 
were designed to amplify the fusion sequence and the wildtype sequence; the same reverse 104 
primer was used to amplify the two sequences, since the 3’ end of both sequences consists of the 105 
same ALK wildtype portion. The sense strand of the PCR products would be immobilized on the 106 
glass slide using the complementary sequence of the forward primer as the capture strand; the 3’ 107 
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amino labelled capture strands (antisense) were designed in order to stick out the target strand 108 
away from the slide surface.  109 
Analysis of Tm and hairpin for the target strands, primers and probes was achieved using 110 
software such as MFOLD, IDT and New England Biolabs (NEB) Tm calculators to ensure 111 
optimal hybridization thermodynamics (23-27). 112 
Amplification of fusion and wildtype sequences  113 
PCR buffer and Taq DNA polymerase were obtained from Applied Biological Materials Inc. 114 
(Richmond, BC, Canada) and dNTP’s from Thermo Scientific Inc. (Waltham, MA, USA). PCR 115 
was performed in a 50 µL reaction volume and reagent concentrations were 1X PCR Buffer, 200 116 
µM of each nucleotide (dATP, dGTP, dCTP, dTTP), 300 nM each of forward and reverse 117 
primers if symmetric PCR products were desired or 450 nM and 150 nM of forward and reverse 118 
primers, respectively, if asymmetric PCR products were desired, 10 ng DNA template (either 119 
fusion or wildtype), and 5U Taq DNA polymerase. PCR was performed using the 3Prime 120 
thermocycler (Techne). Thermal cycling parameters started with a 3 min 94°C initial 121 
denaturation followed by 30 cycles of 95 °C (denaturation), 50 °C (annealing), and 72 °C 122 
(elongation) each for 30 s. PCR amplified products were purified using a PCR purification kit 123 
(Qiagen). Following purification, the ratios of DNA absorbances at specific wavelengths (nm), 124 
i.e. 260/230 ratio and 260/280 ratio, were obtained using the Nanodrop spectrometer analysis. If 125 
the 260/230 ratio was close to 2-2.22 and the 260/280 ratio was close to 1.8, the products were 126 
deemed pure and were used in subsequent experiments. The symmetric PCR products were 127 
diluted to 22 ng/µL in hybridization buffer, and the the fusion and wildtype asymmetric PCR 128 




Immobilization of target strands and hybridization of probes 131 
Once the glass slide was functionalized, the target strands were immobilized onto the glass slide, 132 
as previously described (28). First, the PDMS slab was washed with ethanol and water and dried 133 
after which it was sealed onto the functionalized glass slides. Next, 1 µL of the 5’ amine-labelled 134 
target solutions (or 3’-amine-labeled capture strands), all of which were diluted to 25 µM using 135 
1.5 M NaCl and 0.15 M NaHCO3 (immobilization buffer), were injected by a pipettor into the 136 
wells of the PDMS slab. Suction was applied to the wells on the opposite side of the slab to pull 137 
the solution into the microchannels.  138 
The targets were allowed to react and attach to the functionalized glass slide for 1 h after which 139 
the solution was pumped out of the channels, followed by a wash of the channels with the 140 
immobilization buffer to get rid of any excess target strands. Next, the glass slide was put into a 141 
2.5 mg/mL NaBH4 bath for 15 min to reduce the imine on the target strand to an amine. The 142 
glass slide was then washed with 1X PBS and dried, resulting in straight lines of the target 143 
strands immobilized onto the glass slide.  144 
After target strand immobilization, a second PDMS slab was reversibly sealed onto the glass 145 
slide so that the biotin-labelled probe solutions (EML4 or ALK) would flow perpendicular to the 146 
lines of the immobilized target strands (Fig. 1). One µL of probe solutions (25 nM) were diluted 147 
in 1X SSC (0.15 M NaCl + 0.015 M citrate), and 0.1% sodium dodecyl sulfate (SDS) to the 148 
needed concentrations, and were injected into the microchannels and allowed to hybridize to the 149 
immobilized target strands for 1 h. Excess solution was then removed from the channels, and the 150 
channels were subsequently washed with 1X PBS. Next, 1 µL of a 50 ng/mL streptavidin-Cy5 151 
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solution was introduced into the channels and allowed to bind to the biotin label on the probes 152 
for 15 min. This was followed by a wash with Tween solution in 1X PBS. The PDMS slab was 153 
peeled off and the glass slide was now ready for fluorescence scanning. 154 
  155 
Immobilization of capture strands and hybridization first of PCR sense strand and then of 156 
probes 157 
Immobilization of 3’-amine-labeled capture strands and subsequent washing and reduction are 158 
similar to what are described in the preceding section for the 5’-amine-labeled target strands. 159 
After capture strand immobilization, a second PDMS slab was reversibly sealed onto the glass 160 
slide so that the PCR products (fusion or WT) would flow perpendicular to the lines of the 161 
immobilized antisense capture strands. These capture strands captured the sense strands of the 162 
PCR products, which were diluted before each experiment to the indicated concentrations, both 163 
in hybridization buffer.  164 
With the PDMS slab still in place, 1 µL of probe solutions (25 nM), prepared in a similar way as 165 
in the preceding section, was injected into the microchannels by a pipettor and allowed to 166 
hybridize to the captured PCR strands for 1 h. Excess solution was then removed from the 167 
channels, and the channels were subsequently washed with 1X PBS. Next, 1 µL of a 50 ng/mL 168 
streptavidin-Cy5 solution was introduced into the channels and allowed to bind to the biotin label 169 
on the probes for 15 min. This was followed by a wash with Tween solution in 1X PBS. The 170 





If the biotin labelled probes were able to hybridize to the complementary target strands or 174 
captured PCR sense strand, then the subsequently introduced streptavidin-Cy5 would bind to the 175 
biotin and fluorescence from the Cy5 would be detected as patches at the appropriate 176 
intersections on the glass surface. However, if hybridization did not occur there would be no 177 
fluorescence at the intersections. The image of fluorescent patches was then uploaded onto the 178 
ImageQuant software and small rectangle boxes were overlaid onto the signals of the image. The 179 
intensity of each rectangular box was then averaged to obtain the intensity of the signal. 180 
 181 
Instruments 182 
Fluorescence scanning was achieved using the Typhoon Trio+ variable mode imager, as 183 
previously used (29), and Biorad ChemiDoc Imager. DNA amplification was conducted on the 184 
Techne 3Prime Thermocycler. Analysis of the quality and quantity of PCR products was 185 
performed on the Nanodrop 2000 spectrometer, and this provides the DNA concentrations and 186 
the 260/280 and 260/230 absorbance ratios which allows assurance that the DNA is pure. 187 
 188 
Results and Discussion 189 
 190 
Testing of the effectiveness of the probes 191 
Two 5’-amine-labelled target strands were immobilized onto the functionalized glass slide and 192 
then allowed to hybridize with both the EML4 and ALK probes. Using this method, we show 193 
that detection of the presence of the 55-mer and 85-mer oligomers is successful. Fig. 2a shows 194 
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that, as expected, both the EML4 and ALK probes hybridize to the 85-mer; whereas the ALK 195 
probe, but not the EML4 probe, hybridizes with the 55-mer. This difference in probe binding is 196 
sufficient in differentiating the 55-mer from the 88-mer. However, the signal intensity generated 197 
from the ALK probe is lower. Fig. 2b shows the signal intensities of the probes that bind to the 198 
respective oligomers.  199 
It was noticed in the hybridization experiment that the 85-mer binds a lot stronger to the EML4 200 
probe than the ALK probe. Upon reviewing the sequence of the probe, it was determined that 201 
ALK probe 1 had no G/C clamp on the 5’ and 3’ ends. The probe was then modified so that it 202 
had a G nucleotide on both ends (ALK Probe 2 in Table 1). In Fig. 3a, the intensity of ALK 203 
probe 2 is more intense than ALK probe 1 indicating that the addition of the G clamps on the 204 
ends of the probe help the ALK probe better bind to both oligomers. Fig. 3b, shows the 205 
difference in intensities between ALK probes 1 and 2, with ALK probe 2 showing greater 206 
intensity. For all subsequent experiments, ALK probe 2 was used. 207 
 208 
Detection of PCR products of the EML4-ALK fusion sequence 209 
Detection of wildtype ALK and mutated EML4-ALK double stranded DNA, which are 210 
unlabeled, required the immobilization of the sense strands on the glass slide surface. A 211 
reasonable choice is the sequence of the forward primer (sense strand) that will certainly be 212 
captured by the antisense capture strand. This capture strand should be labelled on the 3’-end, 213 
rather than the usual 5’-end, so that the captured strand could face away from the glass surface. 214 
Once this 3’-amine-labeled capture strand was immobilized onto the glass slide, the PCR product 215 
was introduced and the antisense strand latched onto the primer (Fig. 4). Subsequently, the 216 





The results are shown in Fig. 5a, which shows that the signals are high for the fusion product to 220 
bind with both the EML4 and ALK probe, but is only high for the WT product to bind with the 221 
ALK probe. Moreover, the asymmetric PCR products give higher signals than the symmetric 222 
products. To obtain a better comparison of probe binding intensities, each PCR hybridization 223 
signal was normalized to the oligomer hybridization signal within the same channel. In this way, 224 
the successful detection of the sense strand of the PCR products was defined using a signal 225 
intensity threshold normalized to the background, see Fig. 5b. It shows that the fusion product 226 
binds to both the EML4 and ALK probes whereas the wildtype product binds only the ALK 227 
probe. Again, this difference in probe binding is sufficient in differentiating between the 228 
wildtype and fusion product. Since the asymmetric PCR products gave higher signals than the 229 
symmetric products, for all future experiments, it was decided that only the asymmetric PCR 230 
products would be used.  231 
 232 
Since the ratio of mutant to wild-type DNA (i.e. mutation frequency) can vary in a given 233 
individual, a study was conducted to see how low of a mutant frequency can be detected in our 234 
biochip. Asymmetric PCR products of both fusion and WT sequences were mixed to obtain 235 
wildtype:fusion ratios of 75:25, 90:10, and 99:1. All these mixtures were diluted in hybridization 236 
buffer to the same volume. The concentration of the ALK and EML4 probes was increased to 50 237 
nM, and 0.8 µL of the PCR product solutions were introduced twice into each channel. Detection 238 
of both the fusion and WT sequences was successful with all the mixtures listed above. Fig. 6a 239 
shows that our method is capable of detecting and differentiating the fusion and wildtype PCR 240 
12 
 
products in even the 99:1 mixture, in which the amount of fusion sequence is only 1% and at a 241 
final concentration of 0.25 ng/µL. Fig. 6b shows signal intensities of the three mixtures. The star 242 
above a bar indicates that the detection threshold was met. As can be seen in the graph, 243 
successful detection and differentiation was obtained for all 3 mixtures. 244 
  245 
Conclusion 246 
Detection of the EML4-ALK fusion gene and differentiation between the WT and fusion 247 
sequences has been accomplished using a microfluidic biochip. First, single stranded oligomers 248 
were directly immobilized, and the probes were subsequently introduced for detection. Next, we 249 
show that adding G clamps to the end of the ALK probe can increase the binding of this probe to 250 
the target sequences. Detection and differentiation of the fusion and WT PCR products was 251 
accomplished after immobilizing the antisense strands. Our study shows the ability to detect WT 252 
and fusion products in even the 99:1 mixture, in which the concentration of the fusion 253 
asymmetric PCR product is only 0.25 ng/µL. Further studies will be conducted by extracting 254 
mRNA from cells known to contain the EML4-ALK fusion, reverse-transcribing mRNA to 255 
cDNA, and detecting them using the method described in this work. 256 
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Table 1. DNA Sequences for target strands, primers, and probes. Red represents the portions 378 
of the ALK gene in the fusion and the wildtype ALK (WT) strand; blue represents portions of 379 
the EML4 gene in the fusion strand 380 
DNA strand Nucleotide Sequence and Functionalization 
ALK Probe 1 Biotin-5’-TGGCTTGCAGCTCCT-3’ 
ALK Probe 2 Biotin-5’-GGCTTGCAGCTCCTG-3’ 
EML4 Probe Biotin-5’-CTCTACAGTAGTTTTGCTC C-3’ 























5’-TGGAGACTCA GGTGGAGTCA TGCTTATATG GAGCAAAACT 
ACTGTAGAGC CCACACCTGG GAAAGGACCT AAAGTGTACCG 




5’-TGATCCTC TCTGTGGTGA CCTCTGCCCT CGTGGCCGCC 



















Fig. 1 Flow scheme of the hybridization experiments. One PDMS slab consisting of 388 
microchannels with wells on either ends of them. The slab is sealed with a glass slide and then 389 
solutions are injected into the channels. As the solution rests inside the capillaries, it interacts 390 
with the glass slide. Samples containing the target sequences are injected into the channels and 391 
allowed to interact and immobilize to the glass slide. Removal of the slab allowed the covalently-392 
immobilized target sequences on the glass slides to be exposed for subsequent reaction (red 393 
lines). Another PDMS slab is sealed perpendicular to the immobilized target sequences on the 394 
glass slide. Biotin-labelled probe solutions (green) are injected into the channels and allows to 395 
hybridize with the immobilized target strands (red). The dots show fluorescent signals which 396 
indicates the sites of successful hybridization. 397 
 398 
Fig. 2 Detection using the EML4 and ALK probes: a) Images of the binding of EML4 and ALK 399 
probes with 85-mer and 55-mer sequences. b) Signal intensities show good differentiation 400 
between the 88-mer and 55-mer sequences (error bars are standard deviation of 9 measurements). 401 
 402 
Fig. 3 Use of ALK probe 2 enhanced hybridization intensity: a) ALK probe 2 with G clamps on 403 
either end binds better to the oligomers. b) Hybridization intensity of ALK probe 2 is greater 404 




Fig. 4 The 3-strand hybridization method used to obtain signals for the EML4-ALK sense PCR 407 
product strands 408 
 409 
Fig. 5 Asymmetric vs. symmetric PCR product binding intensities. a) Successful detection is 410 
defined as a signal intensity greater than 20,000 when normalized to the background (as 411 
represented by the dotted line) and is indicated by the red star. b) PCR hybridization signals are 412 
normalized to the oligomer hybridization signals in the same channel for binding comparison. 413 
The signals are stronger for the asymmetric products than for the symmetric ones (error bars 414 
show standard deviation of 3 measurements) 415 
 416 
Fig. 6 Detection of the fusion product among the WT one: a) Images for the detection of both the 417 
fusion and WT sequences at a 99:10 wildtype:fusion PCR product mixture. b) Signal intensity 418 
graph shows ability to detect and differentiate between fusion and WT PCR product mixtures of 419 




















Flow scheme of the hybridization experiments performed using the microfluidic chip. 438 
